WELCOME TO The HEALTHCARE REPORT
Newsletter | Member Login | Signup
Home > Companies > Brightpoint Health
Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...
Conference
HealthIT Analytics | April 10, 2020
As the COVID-19 pandemic continues to disrupt the status quo, the healthcare industry is turning to real-world data to better understand, monitor, and prepare for whatever the virus may bring. From patient surveys and EHR information, to studies on past outbreaks and hospital capacity, leaders are harnessing the power of real-world data to observe patterns and make critical decisions. Defined by the FDA as information derived from sources other than traditional clinical trials, real-world ...
Health Technology
Royal Philips | November 28, 2022
Royal Philips a global leader in health technology announced its portfolio of smart diagnostic systems and transformative workflow solutions featured at the Radiological Society of North America annual meeting. Powered by AI, the company will showcase its latest systems and informatics solutions designed for providers to efficiently deliver patient-centric, high-quality imaging services. Overwhelming volume of radiology data compounding staff shortages and burnout Read More
MedCrypt, Inc. | November 18, 2020
MedCrypt Inc., the main supplier of proactive security answers for the medical care space, today declared Accuray has picked MedCrypt's Software Bill of Materials (SBOM) and Vulnerability Tracking Software, Heimdall, to help upgrade observing the advanced security stance of the organization's arrangement of radiation therapy conveyance, arranging, and information the executives arrangements. Accuray innovations ...
Novartis Pharma AG | September 19, 2022
Sandoz, a global leader in off-patent medicines, announces further progress on its biosimilar pipeline, with the release of positive results from the integrated ROSALIA Phase I/III clinical trial study for its proposed biosimilar denosumab. “Biosimilars have the opportunity to create a substantial positive impact on patient access and healthcare systems sustainability. Therefore, this important milestone means that we are one step closer to giving individ...
Digital Healthcare
Video
AI, Future of Healthcare
none
Whitepaper
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Welcome back!
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up
Sign up to contribute and publish your news, events, brand, and content with the community for FREE